TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis - PubMed (original) (raw)
TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis
S Kanzler et al. Am J Physiol. 1999 Apr.
Abstract
Transforming growth factor-beta1 (TGF-beta1) is a powerful stimulus for collagen formation in vitro. To determine the in vivo effects of TGF-beta1 on liver fibrogenesis, we generated transgenic mice overexpressing a fusion gene [C-reactive protein (CRP)/TGF-beta1] consisting of the cDNA coding for an activated form of TGF-beta1 under the control of the regulatory elements of the inducible human CRP gene promoter. Two transgenic lines were generated with liver-specific overexpression of mature TGF-beta1. After induction of the acute phase response (15 h) with lipopolysaccharide (100 microgram ip), plasma TGF-beta1 levels reached >600 ng/ml in transgenic animals, which is >100 times above normal plasma levels. Basal plasma levels of uninduced transgenic animals were about two to five times above normal. As a consequence of hepatic TGF-beta1 expression, we could demonstrate marked transient upregulation of procollagen I and procollagen III mRNA in the liver 15 h after the peak of TGF-beta1 expression. Liver histology after repeated induction of transgene expression showed an activation of hepatic stellate cells in both transgenic lines. The fibrotic process was characterized by perisinusoidal deposition of collagen in a linear pattern. This transgenic mouse model gives in vivo evidence for the important role of TGF-beta1 in stellate cell activation and liver fibrogenesis. Due to the ability to control the level of TGF-beta1 expression, this model allows the study of the regulation and kinetics of collagen synthesis and fibrolysis as well as the degree of reversibility of liver fibrosis. The CRP/TGF-beta1 transgenic mouse model may finally serve as a model for the testing of antifibrogenic agents.
Similar articles
- Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis.
Ueberham E, Löw R, Ueberham U, Schönig K, Bujard H, Gebhardt R. Ueberham E, et al. Hepatology. 2003 May;37(5):1067-78. doi: 10.1053/jhep.2003.50196. Hepatology. 2003. PMID: 12717387 - Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A.
Thieringer F, Maass T, Czochra P, Klopcic B, Conrad I, Friebe D, Schirmacher P, Lohse AW, Blessing M, Galle PR, Teufel A, Kanzler S. Thieringer F, et al. Gene. 2008 Oct 15;423(1):23-8. doi: 10.1016/j.gene.2008.05.022. Epub 2008 Jun 10. Gene. 2008. PMID: 18598744 - Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.
Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. Sanderson N, et al. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2572-6. doi: 10.1073/pnas.92.7.2572. Proc Natl Acad Sci U S A. 1995. PMID: 7708687 Free PMC article. - Experimental and human liver fibrogenesis.
Kovalszky I, Nagy P, Szende B, Lapis K, Szalay F, Jeney A, Schaff Z. Kovalszky I, et al. Scand J Gastroenterol Suppl. 1998;228:51-5. doi: 10.1080/003655298750026561. Scand J Gastroenterol Suppl. 1998. PMID: 9867113 Review. - Multiple forms of TGF-beta: distinct promoters and differential expression.
Roberts AB, Kim SJ, Noma T, Glick AB, Lafyatis R, Lechleider R, Jakowlew SB, Geiser A, O'Reilly MA, Danielpour D, et al. Roberts AB, et al. Ciba Found Symp. 1991;157:7-15; discussion 15-28. doi: 10.1002/9780470514061.ch2. Ciba Found Symp. 1991. PMID: 1906395 Review.
Cited by
- Protective effects of polydatin from Polygonum cuspidatum against carbon tetrachloride-induced liver injury in mice.
Zhang H, Yu CH, Jiang YP, Peng C, He K, Tang JY, Xin HL. Zhang H, et al. PLoS One. 2012;7(9):e46574. doi: 10.1371/journal.pone.0046574. Epub 2012 Sep 28. PLoS One. 2012. PMID: 23029551 Free PMC article. - Leptin induces increased alpha2(I) collagen gene expression in cultured rat hepatic stellate cells.
Saxena NK, Saliba G, Floyd JJ, Anania FA. Saxena NK, et al. J Cell Biochem. 2003 May 15;89(2):311-20. doi: 10.1002/jcb.10494. J Cell Biochem. 2003. PMID: 12704794 Free PMC article. - Deciphering Molecular Mechanisms of Carbon Tetrachloride- Induced Hepatotoxicity: A Brief Systematic Review.
Fareed MM, Khalid H, Khalid S, Shityakov S. Fareed MM, et al. Curr Mol Med. 2024;24(9):1124-1134. doi: 10.2174/0115665240257603230919103539. Curr Mol Med. 2024. PMID: 37818557 - CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation.
Ullah A, Wang K, Wu P, Oupicky D, Sun M. Ullah A, et al. Int J Nanomedicine. 2019 Apr 26;14:2927-2944. doi: 10.2147/IJN.S171280. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31118614 Free PMC article. - The balancing act of the liver: tissue regeneration versus fibrosis.
Cordero-Espinoza L, Huch M. Cordero-Espinoza L, et al. J Clin Invest. 2018 Jan 2;128(1):85-96. doi: 10.1172/JCI93562. Epub 2018 Jan 2. J Clin Invest. 2018. PMID: 29293095 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous